WO2012131699A1 - Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate - Google Patents

Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate Download PDF

Info

Publication number
WO2012131699A1
WO2012131699A1 PCT/IN2011/000721 IN2011000721W WO2012131699A1 WO 2012131699 A1 WO2012131699 A1 WO 2012131699A1 IN 2011000721 W IN2011000721 W IN 2011000721W WO 2012131699 A1 WO2012131699 A1 WO 2012131699A1
Authority
WO
WIPO (PCT)
Prior art keywords
dimethylcarbamate
formula
iii
base
aryl
Prior art date
Application number
PCT/IN2011/000721
Other languages
French (fr)
Inventor
Mahesh Bhagoji Dalvi
Rajesh Shashikant Kenny
Pradeep Kisan Tarade
Dattatray Krishna CHINCHKAR
Original Assignee
Neon Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neon Laboratories Ltd. filed Critical Neon Laboratories Ltd.
Publication of WO2012131699A1 publication Critical patent/WO2012131699A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups

Definitions

  • R ⁇ is an electron withdrawing group
  • R 2 and R 3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R 2 and R 3 when placed ortho to each other form benzene ring
  • R 3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R 3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring.
  • Neostigmine named chemically 3-[[(dimethylamino)carbonyl]oxy]-N,N,N- trimethylbenzenaminium methyl sulfate is a parasympathomimetic that acts as a reversible acetylcholinesterase inhibitor. It is used to improve muscle tone in people with myasthenia gravis and routinely, in anesthesia at the end of an operation, to reverse the effects of non-depolarizing muscle relaxants such as Rocuronium and Vecuronium. It can also be used for urinary retention resulting from general anesthesia and to treat curariform drug toxicity.
  • Neostigmine has following structure:
  • the patent GB342237 discloses the preparation of neostigmine by reaction of 3- dimethylaminophenyl chloroformate with dimethylamine to form 3-dimethylaminophenyl dimethylcarbamate; followed by alkylation of resulting dimethylcarbamate with dimethylsulphate.
  • the process describes benzene as a solvent, and the product is isolated by distillation.
  • 3-dimethylaminophenyl chloroformate is moisture sensitive, hazardous and hence requires dry conditions.
  • the process is carried out in benzene and the product is isolated by distillation. More importantly, the patent does not disclose the purity of 3- dimethylaminophenyl dimethylcarbamate and neostigmine.
  • the European patent EP 193926 discloses the preparation of phenyl carbamates involving reaction of hydroxyphenyl-substituted alkyl amines with appropriate isocyanates or carbamoyl chlorides.
  • the process using isocyanates involves the use of benzene as a solvent.
  • Isocyanates such as lower alkyl isocyanates are hazardous to handle due to their toxic and non-volatile nature.
  • the other alternative reported in this patent is the use of carbamoyl chlorides along with reactive bases like sodium hydride, to prepare the carbamates.
  • the use of a reactive base like sodium hydride on an industrial scale is hazardous and operationally non-user friendly due to its pyrophoric and reactive nature.
  • the US application US20100113819 discloses a method for making carbamates by reacting an amine with an ester-substituted diaryl carbamate. However the method is applicable only for ester-substituted diaryl carbamates and does not teach the preparation of 3-dimethylaminophenyl dimethylcarbamate which does not contain ester group.
  • the US patent 4315861 discloses a process for preparing carbamic acid phenyl ester by O-acylation of phenolic compounds with N-carbamoyl saccharin derivatives. However the patent does not disclose the source of N-carbamoyl saccharin derivatives and does not teach the preparation of 3-dimethylaminophenyl dimethylcarbamate.
  • an object of the invention is to overcome or ameliorate atleast one disadvantage of the prior art or to provide a useful alternative.
  • Another object of the invention is to provide a novel, high yielding process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate which is an intermediate of neostigmine from diaryl carbonate, using mild conditions, avoiding a need of hazardous chemicals and also avoiding purification process such as distillation at high temperature and high vacuum.
  • Another object of the invention is to provide a novel process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate using easily available starting materials and with easy work-up.
  • Yet another object of the invention is to provide a concise, commercially viable and industrially applicable process for preparation of highly pure neostigmine methylsulphate having desirable pharmacological activity, broad safety margins, without toxicity or unfavourable side effects.
  • the present invention provides an economic, industrially feasible and high yielding process for the preparation of highly pure neostigmine intermediate from diaryl carbonate, under mild conditions.
  • the present invention provides a process for preparation of 3- dimethylaminophenyl dimethylcarbamate comprising reacting diaryl carbonate with dimethylamine to form aryl dimethylcarbamate; and reacting aryl dimethylcarbamate with 3-dimethylaminophenol.
  • the present invention provides an alternative process for preparation of aryl dimethylcarbamate comprising reacting dimethylcarbamoyl chloride with a substituted phenol to form an aryl dimethylcarbamate; and reacting aryl dimethylcarbamate with 3-dimethylaminophenol.
  • the present invention provides a process for quaternistion of aryl dimethylcarbamate to provide neostigmine.
  • any of the words 'having', 'including', 'includes', 'comprising' and 'comprises' mean 'including without limitations' and shall not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it.
  • Embodiments of the invention are not mutually exclusive, but may be implemented in various combinations. The described embodiments of the invention and the disclosed examples are given for the purpose illustration rather than limitation of the invention as set forth the appended claims. Accordingly, the present invention provides a process to prepare highly pure 3- dimethylaminophenyl dimethylcarbamate of formula (I)
  • Ri is an electron withdrawing group
  • R 2 and R 3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R 2 and R 3 when placed ortho to each other form benzene ring
  • R 3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R 3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring
  • the process of the present invention is advantageously carried out in one-pot i.e. without isolating aryl dimethylcarbamate of formula (III).
  • Ri is an electron withdrawing group selected from N0 2 , CN or CO-alkyl
  • R 2 is hydrogen or electron withdrawing group selected from N0 2 , CN or CO- alkyl
  • R 3 is hydrogen
  • the reaction of bis(4-nitrophenyl) carbonate or bis(2-nitrophenyl)carbonate with dimethylamine may be carried out at suitable temperature. To minimize the decomposition of products and impurity formation the reaction is carried out at -20°C to 45°C, more preferably at 0° to 35°C. The most preferred reaction temperature is 10°C to 25°C.
  • the step 'a' of the reaction is preferably carried out in a suitable solvent.
  • the reaction of aryl dimethylcarbamate of formula (III) obtained in the step 'a' with 3- dimethylaminophenol is preferably carried out in presence of a base and a suitable solvent.
  • the base which may be used in the present invention is an inorganic base.
  • inorganic base include alkali metal carbonate, alkaline earth metal carbonate, alkali metal bicarbonate, alkaline earth metal bicarbonate, alkali metal hydroxide, alkaline earth metal hydroxide and mixture thereof.
  • alkali metal carbonate include sodium carbonate and potassium carbonate.
  • alkali metal bicarbonate include sodium bicarbonate and potassium bicarbonate.
  • alkaline earth metal carbonate examples include calcium carbonate and magnesium carbonate.
  • alkaline earth metal bicarbonate examples include calcium bicarbonate and magnesium bicarbonate.
  • alkali metal hydroxide examples include potassium hydroxide and sodium hydroxide. The preferred base is potassium hydroxide.
  • the base is conveniently used in an amount, relative to aryl dimethylcarbamate of formula (III), preferably in a range between 0.8 to 2 equivalents, more preferably 1.2 to 1.8 equivalents.
  • the most preferred quantity of the base is 1.4 to 1.6 equivalents.
  • the suitable solvent used according to the process of the invention in both the steps may be selected from any polar solvent, non polar solvent or mixture thereof.
  • the preferred solvent is toluene.
  • reaction of aryl dimethylcarbamate of formula (III) obtained in the step 'a' with 3- dimethylaminophenol may be carried out at 60°C to 145°C, more preferably at 80° to 135°C.
  • the most preferred reaction temperature is 100°C to 125°C.
  • the present invention describes an alternative method for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate of formula (I).
  • the process comprises following steps: i. reacting dimethylcarbamoyl chloride with a substituted phenol of formula (IV) to form an aryl dimethylcarbamate of formula (III)
  • Rj is an electron withdrawing group
  • R 2 and R 3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R 2 and R3 when placed ortho to each other form benzene ring
  • R3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring
  • R ⁇ is an electron withdrawing group selected from N0 2 , CN or CO-alkyl
  • R 2 is hydrogen or electron withdrawing group selected from N0 2 , CN or CO-alkyl
  • R 3 is hydrogen
  • steps 'i' and 'iii' are preferably carried out in presence of a base and a suitable solvent.
  • the base which may be used in the step (i) of present invention is organic or inorganic.
  • the base used for the step (iii) is inorganic.
  • organic base include tertiary amines such as trialkyl amine.
  • inorganic base include alkali metal carbonate, alkaline earth metal carbonate, alkali metal bicarbonate, alkaline earth metal bicarbonate, alkali metal hydroxide, alkaline earth metal hydroxide and mixture thereof.
  • alkali metal carbonate include sodium carbonate and potassium carbonate.
  • alkali metal bicarbonate include sodium bicarbonate and potassium bicarbonate.
  • alkaline earth metal carbonate include calcium carbonate and magnesium carbonate.
  • alkaline earth metal bicarbonate examples include calcium bicarbonate and magnesium bicarbonate.
  • alkali metal hydroxide examples include potassium hydroxide and sodium hydroxide.
  • the preferred base for the step (i) is triethylamine.
  • the preferred base for the step (iii) is potassium hydroxide.
  • the base is conveniently used in an amount, relative to dimethylcarbamoyl chloride, preferably in a range between 1 to 2 equivalents, more preferably 1.2 to 1.8 equivalents.
  • the most preferred quantity of the base is 1.4 to 1.6 equivalents.
  • the base is conveniently used in an amount, relative to aryl dimethylcarbamate of formula (III), preferably in a range between 0.8 to 2 equivalents, more preferably 1.2 to 1.8 equivalents.
  • the most preferred quantity of the base is 1.4 to 1.6 equivalents.
  • the suitable solvent used according to the process of the invention in both the process steps may be selected from any polar solvent, non polar solvent or mixture thereof.
  • the preferred solvent is toluene.
  • the process of the present invention may be carried out at suitable temperature. To minimize the decomposition of products and impurity formation the reaction is carried out at 60°C to 200°C, more preferably at 80°C to 150°C. The most preferred reaction temperature is 100°C to 125°C.
  • the pure 3-dimethylaminophenyl dimethylcarbamate obtained by the process of present invention can be quaternisd with dimethylsulphate using known procedure to afford neostigmine methylsulphate in 81 to 92% yield with 98.8 to 99.7% HPLC purity.
  • the pure neostigmine methylsulphate obtained by the process of the invention may be formulated into a dosage form by combining with one or more pharmaceutically acceptable excipients using known techniques. Further the dosage form may be immediate release or extended release.
  • a 250 ml round bottom flask was charged with 3-dimethylaminophenol (11 gm), potassium hydroxide (4.8 gm) and toluene (120 ml); and the reaction mixture was refluxed at 100°C to 1 10°C for 2 hours.
  • the flask was cooled to room temperature and charged with the filtrate from the step (i).
  • the reaction mixture was refluxed at 100°C to 1 10°C for 1.5 hours and filtered.
  • the filtrate was cooled to room temperature and washed with IN sodium hydroxide solution followed by conventional work-up to afford 3- dimethylaminophenyl dimethylcarbamate.
  • the filtrate obtained in the step (i) of the example 1 was concentrated to dryness and recrystallised from toluene to obtain 4-nitrophenyl dimethylcarbamate.
  • Step (ii) Preparation of 3-dimethylaminophenyl dimethylcarbamate
  • 2-nitrophenyl dimethylcarbamate instead of 2-nitrophenyl dimethylcarbamate.
  • a 1000 ml four neck round bottom flask was charged with 3-dimethylaminophenol (40 gm), potassium hydroxide (18.7 gm) and toluene (200 ml).
  • the flask was heated to reflux for one hour, cooled to 90°C and charged with the toluene layer obtained in the step (i).
  • the reaction mixture was heated to reflux and maintained for 3 hours.
  • the reaction mixture was filtered, residue was washed with toluene, followed by conventional work-up to afford 3-dimethylaminophenyl dimethylcarbamate.
  • the toluene layer which was obtained as per the step (i) of the example 5 was washed with distilled water (500 ml). The organic layer was dried over sodium sulphate and concentrated to dryness. The residue obtained was triturated with hexane and collected by filtration to afford 4-nitrophenyl dimethylcarbamate.
  • a 1000 ml four neck round bottom flask was charged with 3-dimethylaminophenol (60 gm), potassium hydroxide (28.05 gm) and toluene (300 ml). The flask was heated to reflux for one hour and cooled to 90°C. The flask was charged with 4-nitrophenyl dimethylcarbamate (54 gm), heated to reflux and maintained for 3 hours. The reaction mixture was filtered and residue was washed with toluene. The toluene layer was washed with 0.5 N sodium hydroxide solution; followed by conventional work-up to afford 3- dimethylaminophenyl dimethylcarbamate.
  • step (i) of example 6 The process is carried out similarly as step (i) of example 6, using 2-nitrophenol instead of 4-nitrophenol to afford 2-nitrophenyl dimethylcarbamate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a novel process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate via formation of aryl dimethylcarbamate which can be easily obtained from diaryl carbonate and dimethylamine.

Description

"PROCESS FOR PREPARATION OF HIGHLY PURE 3- DIMETHYLAMINOPHENYL DIMETHYLCARBAMATE"
TECHNICAL FIELD:
The present invention relates to a novel process for preparation of highly pure 3- dimethylaminophenyl dimethylcarbamate of formula (I), an intermediate of neostigmine, from diaryl carbonate of formula (II), under mild conditions.
Figure imgf000002_0001
Formula (II) where R\ is an electron withdrawing group; R2 and R3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R2 and R3 when placed ortho to each other form benzene ring; R3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring.
BACKGROUND AND PRIOR ART:
Neostigmine named chemically 3-[[(dimethylamino)carbonyl]oxy]-N,N,N- trimethylbenzenaminium methyl sulfate is a parasympathomimetic that acts as a reversible acetylcholinesterase inhibitor. It is used to improve muscle tone in people with myasthenia gravis and routinely, in anesthesia at the end of an operation, to reverse the effects of non-depolarizing muscle relaxants such as Rocuronium and Vecuronium. It can also be used for urinary retention resulting from general anesthesia and to treat curariform drug toxicity.
Neostigmine has following structure:
Figure imgf000003_0001
Neostigmine was disclosed in the US patent 1905990, where it was obtained by reaction of 3-dimethylaminophenol with N-dimethylcarbamoyl chloride to form 3- dimethylaminophenyl dimethylcarbamate; followed by alkylation of resulting dimethylcarbamate using dimethylsulphate. The process describes benzene as a solvent, and the product is isolated by distillation. The process of distillation is not at all industrially applicable as it is time consuming, and requires high temperature and separate set up. Also the patent does not disclose the purity of 3-dimethylaminophenyl dimethylcarbamate and neostigmine.
The patent GB342237 discloses the preparation of neostigmine by reaction of 3- dimethylaminophenyl chloroformate with dimethylamine to form 3-dimethylaminophenyl dimethylcarbamate; followed by alkylation of resulting dimethylcarbamate with dimethylsulphate. The process describes benzene as a solvent, and the product is isolated by distillation.
3-dimethylaminophenyl chloroformate is moisture sensitive, hazardous and hence requires dry conditions. The process is carried out in benzene and the product is isolated by distillation. More importantly, the patent does not disclose the purity of 3- dimethylaminophenyl dimethylcarbamate and neostigmine.
The European patent EP 193926 discloses the preparation of phenyl carbamates involving reaction of hydroxyphenyl-substituted alkyl amines with appropriate isocyanates or carbamoyl chlorides. The process using isocyanates involves the use of benzene as a solvent. Isocyanates such as lower alkyl isocyanates are hazardous to handle due to their toxic and non-volatile nature. The other alternative reported in this patent is the use of carbamoyl chlorides along with reactive bases like sodium hydride, to prepare the carbamates. The use of a reactive base like sodium hydride on an industrial scale is hazardous and operationally non-user friendly due to its pyrophoric and reactive nature. The US application US20100113819 discloses a method for making carbamates by reacting an amine with an ester-substituted diaryl carbamate. However the method is applicable only for ester-substituted diaryl carbamates and does not teach the preparation of 3-dimethylaminophenyl dimethylcarbamate which does not contain ester group.
The US patent 4315861 discloses a process for preparing carbamic acid phenyl ester by O-acylation of phenolic compounds with N-carbamoyl saccharin derivatives. However the patent does not disclose the source of N-carbamoyl saccharin derivatives and does not teach the preparation of 3-dimethylaminophenyl dimethylcarbamate.
Needless to say it is advantageous to develop a process for preparation of highly pure 3- dimethylaminophenyl dimethylcarbamate, which eliminates the necessity of hazardous substances such as chloroformates, highly toxic reagents such as isocyanates, dry reaction conditions and distillation.
OBJECT OF THE INVENTION:
It is therefore an object of the invention is to overcome or ameliorate atleast one disadvantage of the prior art or to provide a useful alternative.
Another object of the invention is to provide a novel, high yielding process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate which is an intermediate of neostigmine from diaryl carbonate, using mild conditions, avoiding a need of hazardous chemicals and also avoiding purification process such as distillation at high temperature and high vacuum.
Another object of the invention is to provide a novel process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate using easily available starting materials and with easy work-up.
Yet another object of the invention is to provide a concise, commercially viable and industrially applicable process for preparation of highly pure neostigmine methylsulphate having desirable pharmacological activity, broad safety margins, without toxicity or unfavourable side effects. SUMMARY OF THE INVENTION.
In accordance with the above objectives, the present invention provides an economic, industrially feasible and high yielding process for the preparation of highly pure neostigmine intermediate from diaryl carbonate, under mild conditions.
According to one aspect, the present invention provides a process for preparation of 3- dimethylaminophenyl dimethylcarbamate comprising reacting diaryl carbonate with dimethylamine to form aryl dimethylcarbamate; and reacting aryl dimethylcarbamate with 3-dimethylaminophenol.
In another aspect, the present invention provides an alternative process for preparation of aryl dimethylcarbamate comprising reacting dimethylcarbamoyl chloride with a substituted phenol to form an aryl dimethylcarbamate; and reacting aryl dimethylcarbamate with 3-dimethylaminophenol.
In a further aspect, the present invention provides a process for quaternistion of aryl dimethylcarbamate to provide neostigmine.
DETAILED DESCRD7TION OF THE INVENTION:
Unless specified otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art, to which this invention belongs. Although any methods and material or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are described. To describe the invention, certain terms are defined herein specified as follows:
Unless stated to the contrary, any of the words 'having', 'including', 'includes', 'comprising' and 'comprises' mean 'including without limitations' and shall not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it. Embodiments of the invention are not mutually exclusive, but may be implemented in various combinations. The described embodiments of the invention and the disclosed examples are given for the purpose illustration rather than limitation of the invention as set forth the appended claims. Accordingly, the present invention provides a process to prepare highly pure 3- dimethylaminophenyl dimethylcarbamate of formula (I)
Figure imgf000006_0001
Formula (I)
comprising following steps: a. reacting diaryl carbonate of formula (II) with dimethylamine to form an aryl dimethylcarbamate of formula (III)
Figure imgf000006_0002
Formula (III) where Ri is an electron withdrawing group; R2 and R3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R2 and R3 when placed ortho to each other form benzene ring; R3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring; b. optionally isolating the aryl dimethylcarbamate of formula (III) obtained in the step 'a'; and c. reacting the aryl dimethylcarbamate of formula (III) obtained in the step 'a', with 3- dimethylaminophenol.
Thus the process avoids the use of water sensitive chloroformate.
The process of the present invention is advantageously carried out in one-pot i.e. without isolating aryl dimethylcarbamate of formula (III).
In a preferred embodiment Ri is an electron withdrawing group selected from N02, CN or CO-alkyl; R2 is hydrogen or electron withdrawing group selected from N02, CN or CO- alkyl; and R3 is hydrogen.
The reaction is carried out by reacting bis(4-nitrophenyl) carbonate or bis(2-nitrophenyl) carbonate with dimethylamine to form a 4-nitrophenyl dimethylcarbamate or 2- nitrophenyl dimethylcarbamate respectively. The resulting 4-nitrophenyl dimethylcarbamate or 2-nitrophenyl dimethylcarbamate is reacted with 3- dimethylaminophenol to obtain 3-dimethylaminophenyl dimethylcarbamate.
The reaction of bis(4-nitrophenyl) carbonate or bis(2-nitrophenyl)carbonate with dimethylamine may be carried out at suitable temperature. To minimize the decomposition of products and impurity formation the reaction is carried out at -20°C to 45°C, more preferably at 0° to 35°C. The most preferred reaction temperature is 10°C to 25°C.
The step 'a' of the reaction is preferably carried out in a suitable solvent. The reaction of aryl dimethylcarbamate of formula (III) obtained in the step 'a' with 3- dimethylaminophenol is preferably carried out in presence of a base and a suitable solvent. The base which may be used in the present invention is an inorganic base. Examples of inorganic base include alkali metal carbonate, alkaline earth metal carbonate, alkali metal bicarbonate, alkaline earth metal bicarbonate, alkali metal hydroxide, alkaline earth metal hydroxide and mixture thereof. Examples of alkali metal carbonate include sodium carbonate and potassium carbonate. Examples of alkali metal bicarbonate include sodium bicarbonate and potassium bicarbonate. Examples of alkaline earth metal carbonate include calcium carbonate and magnesium carbonate. Examples of alkaline earth metal bicarbonate include calcium bicarbonate and magnesium bicarbonate. The examples of alkali metal hydroxide include potassium hydroxide and sodium hydroxide. The preferred base is potassium hydroxide.
The base is conveniently used in an amount, relative to aryl dimethylcarbamate of formula (III), preferably in a range between 0.8 to 2 equivalents, more preferably 1.2 to 1.8 equivalents. The most preferred quantity of the base is 1.4 to 1.6 equivalents.
The suitable solvent used according to the process of the invention in both the steps may be selected from any polar solvent, non polar solvent or mixture thereof. The preferred solvent is toluene.
The reaction of aryl dimethylcarbamate of formula (III) obtained in the step 'a' with 3- dimethylaminophenol may be carried out at 60°C to 145°C, more preferably at 80° to 135°C. The most preferred reaction temperature is 100°C to 125°C.
The resulting 3-dimethylaminophenyl dimethylcarbamate is isolated as a pale yellow oil in 88 - 96% yield with HPLC purity greater than 98%, hence the process avoids the step of distillation which was essentially required for purification in the prior art processes.
In another embodiment, the present invention describes an alternative method for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate of formula (I).
Figure imgf000009_0001
Formula (I)
The process comprises following steps: i. reacting dimethylcarbamoyl chloride with a substituted phenol of formula (IV) to form an aryl dimethylcarbamate of formula (III)
Figure imgf000009_0002
Formula (III) Formula (IV) where Rj is an electron withdrawing group; R2 and R3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R2 and R3 when placed ortho to each other form benzene ring; R3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring; ii. optionally isolating the aryl dimethylcarbamate of formula (III) obtained in the step '; and iii. reacting the aryl dimethylcarbamate of formula (III) obtained in the step with 3- dimethylaminophenol.
The process of the present invention is advantageously carried out in one-pot i.e. without isolating aryl dimethylcarbamate of formula (III). In a preferred embodiment R\ is an electron withdrawing group selected from N02, CN or CO-alkyl; and R2 is hydrogen or electron withdrawing group selected from N02, CN or CO-alkyl; and R3 is hydrogen.
The steps 'i' and 'iii' are preferably carried out in presence of a base and a suitable solvent.
The base which may be used in the step (i) of present invention is organic or inorganic. The base used for the step (iii) is inorganic. Examples of organic base include tertiary amines such as trialkyl amine. Examples of inorganic base include alkali metal carbonate, alkaline earth metal carbonate, alkali metal bicarbonate, alkaline earth metal bicarbonate, alkali metal hydroxide, alkaline earth metal hydroxide and mixture thereof. Examples of alkali metal carbonate include sodium carbonate and potassium carbonate. Examples of alkali metal bicarbonate include sodium bicarbonate and potassium bicarbonate. Examples of alkaline earth metal carbonate include calcium carbonate and magnesium carbonate. Examples of alkaline earth metal bicarbonate include calcium bicarbonate and magnesium bicarbonate. The examples of alkali metal hydroxide include potassium hydroxide and sodium hydroxide. The preferred base for the step (i) is triethylamine. The preferred base for the step (iii) is potassium hydroxide.
The base is conveniently used in an amount, relative to dimethylcarbamoyl chloride, preferably in a range between 1 to 2 equivalents, more preferably 1.2 to 1.8 equivalents. The most preferred quantity of the base is 1.4 to 1.6 equivalents.
The base is conveniently used in an amount, relative to aryl dimethylcarbamate of formula (III), preferably in a range between 0.8 to 2 equivalents, more preferably 1.2 to 1.8 equivalents. The most preferred quantity of the base is 1.4 to 1.6 equivalents.
The suitable solvent used according to the process of the invention in both the process steps may be selected from any polar solvent, non polar solvent or mixture thereof. The preferred solvent is toluene. The process of the present invention may be carried out at suitable temperature. To minimize the decomposition of products and impurity formation the reaction is carried out at 60°C to 200°C, more preferably at 80°C to 150°C. The most preferred reaction temperature is 100°C to 125°C.
The resulting 3-dimethylaminophenyl dimethylcarbamate is isolated as a pale yellow oil in 75 - 96% yield with HPLC purity greater than 98%, hence the process avoids the step of distillation which was essentially required for purification in the prior art processes.
The pure 3-dimethylaminophenyl dimethylcarbamate obtained by the process of present invention can be quaternisd with dimethylsulphate using known procedure to afford neostigmine methylsulphate in 81 to 92% yield with 98.8 to 99.7% HPLC purity.
The pure neostigmine methylsulphate obtained by the process of the invention may be formulated into a dosage form by combining with one or more pharmaceutically acceptable excipients using known techniques. Further the dosage form may be immediate release or extended release.
Further details of the process of the present invention will be apparent from the examples presented below. Examples presented are purely illustrative and are not limited to the particular embodiments illustrated herein but include the permutations, which are obvious as set forth in the description.
EXAMPLES:
Example 1
One-pot preparation of 3-dimethylaminophenyl dimethylcarbamate from bis(4- nitrophenyl)carbonate
Step (i)
A 250 ml round bottom flask was charged with bis(4-nitrophenyl)carbonate (20.5 gm) and toluene (100 ml); and the flask was cooled to 0°C to 5°C. Dimethylamine (9.22 gm, 40% aq. solution) was diluted with 10 ml water and added drop wise to the flask at 0°C to 5°C. After completion of addition the flask was kept at room temperature for stirring for 3 hours. The reaction mixture was washed with saturated sodium chloride solution, dried over sodium sulphate and filtered. The filtrate was used in the next step.
Step (ii)
A 250 ml round bottom flask was charged with 3-dimethylaminophenol (11 gm), potassium hydroxide (4.8 gm) and toluene (120 ml); and the reaction mixture was refluxed at 100°C to 1 10°C for 2 hours. The flask was cooled to room temperature and charged with the filtrate from the step (i). The reaction mixture was refluxed at 100°C to 1 10°C for 1.5 hours and filtered. The filtrate was cooled to room temperature and washed with IN sodium hydroxide solution followed by conventional work-up to afford 3- dimethylaminophenyl dimethylcarbamate.
Yield - 12.2 gm (89.70%)
Nature - pale yellow oil
HPLC Purity - 98.42%
Example 2
Preparation of 3-dimethylaminophenyl dimethylcarbamate from bis(4- nitrophenyl)carbonate
Step (i) Preparation of 4-nitrophenyl dimethylcarbamate
The filtrate obtained in the step (i) of the example 1 was concentrated to dryness and recrystallised from toluene to obtain 4-nitrophenyl dimethylcarbamate.
Yield - 13 gm (91.81%)
Nature - light yellow crystalline powder
HPLC Purity - 96.5%
Step (ii) 3-dimethylaminophenyl dimethylcarbamate
A 250 ml round bottom flask was charged with potassium hydroxide (2.24 gm), 3- dimethylaminophenol (5 gm) and toluene (50 ml). The reaction mixture was refluxed at 100°C to 110°C for 2 hours and cooled to room temperature. 4-nitrophenyl dimethylcarbamate (6.5 gm) was added to the flask and refluxed at 100°C to 110°C for 2.5 hours. The reaction mixture was washed IN sodium hydroxide solution, followed by conventional work-up to afford 3-dimethylaminophenyl dimethylcarbamate.
Yield - 5.98 gm (93%)
Nature - pale yellow oil
HPLC Purity - 98.99%
Example 3
One-pot preparation of 3-dimethylaminophenyl dimethylcarbamate from bis(2- nitrophenyl)carbonate
The process is carried out similarly as example 1 using bis(2-nitrophenyl)carbonate instead of bis(4-nitrophenyl)carbonate.
Yield - 88%
Nature - pale yellow oil
HPLC Purity - 98.90%
Example 4
Preparation of 3-dimethylaminophenyl dimethylcarbamate from bis(2- nitropheny l)carbonate .
Step (i) Preparation of 2-nitrophenyl dimethylcarbamate
The process is carried out similarly as example 2 using bis(2-nitrophenyl)carbonate instead of bis(4-nitrophenyl)carbonate to provide 2-nitrophenyl dimethylcarbamate.
Yield 88%
Nature pale yellow
HPLC Purity - 98.90%
Step (ii) Preparation of 3-dimethylaminophenyl dimethylcarbamate The process is carried out similarly as example 2 using 2-nitrophenyl dimethylcarbamate instead of 2-nitrophenyl dimethylcarbamate.
Yield - 96%
Nature - pale yellow oil
HPLC Purity - 98.10%
Example 5
One-pot preparation of 3-dimethylaminophenyl dimethylcarbamate from 4-nitrophenol Step (i)
A 1000 ml four neck round bottom flask with water condenser was charged with 4- nitrophenol (40 gm) and toluene (300 ml); and heated to reflux. Cool the reaction mixture to room temperature. Triethylamine (44.34 gm) was added to the flask, stirred the reaction mixture for 0.5 hour at room temperature. Dimethylcarbamoyl chloride (29.12 ml) was added drop wise to the flask within 10 to 15 minutes, the reaction mixture was heated to reflux and maintained for 3 hours. The reaction mixture was quenched into distilled water, toluene layer was separated.
Step (ii)
A 1000 ml four neck round bottom flask was charged with 3-dimethylaminophenol (40 gm), potassium hydroxide (18.7 gm) and toluene (200 ml). The flask was heated to reflux for one hour, cooled to 90°C and charged with the toluene layer obtained in the step (i). The reaction mixture was heated to reflux and maintained for 3 hours. The reaction mixture was filtered, residue was washed with toluene, followed by conventional work-up to afford 3-dimethylaminophenyl dimethylcarbamate.
Yield - 50 gm (83.70%)
Nature - pale yellow oil
HPLC Purity - 99.4%
Example 6
Preparation of 3-dimethylaminophenyl dimethylcarbamate from 4-nitrophenol Step (i) Preparation of 4-nitrophenyl dimethylcarbamate
The toluene layer which was obtained as per the step (i) of the example 5 was washed with distilled water (500 ml). The organic layer was dried over sodium sulphate and concentrated to dryness. The residue obtained was triturated with hexane and collected by filtration to afford 4-nitrophenyl dimethylcarbamate.
Yield - 55 gm
Nature - light yellow crystalline powder
HPLC Purity - 99.8%
Step (ii) Preparation of 3-dimethylaminophenyl dimethylcarbamate
A 1000 ml four neck round bottom flask was charged with 3-dimethylaminophenol (60 gm), potassium hydroxide (28.05 gm) and toluene (300 ml). The flask was heated to reflux for one hour and cooled to 90°C. The flask was charged with 4-nitrophenyl dimethylcarbamate (54 gm), heated to reflux and maintained for 3 hours. The reaction mixture was filtered and residue was washed with toluene. The toluene layer was washed with 0.5 N sodium hydroxide solution; followed by conventional work-up to afford 3- dimethylaminophenyl dimethylcarbamate.
Yield - 51.5 gm (96.20%)
Nature - pale yellow oil
HPLC Purity - 99.50%
Example 7
One-pot preparation of 3-dimethylaminophenyl dimethylcarbamate from 2-nitrophenol
The process is carried out similar to the example 5 using 2-nitrophenol instead of 4- nitrophenol.
The product was isolated as pale yellow oil (75% yield) and 97.94% HPLC purity.
Yield - 75%
Nature - pale yellow oil
HPLC Purity - 97.94% Example 8
Preparation of 3-dimethylaminophenyl dimethylcarbamate from 2-nitrophenol
Step (i) Preparation of 2-nitrophenyl dimethylcarbamate
The process is carried out similarly as step (i) of example 6, using 2-nitrophenol instead of 4-nitrophenol to afford 2-nitrophenyl dimethylcarbamate.
Yield - 88%
Nature - light yellow crystalline powder
HPLC Purity - 97.94%
Step (ii) Preparation of 3-dimethylaminophenyl dimethylcarbamate
The process is carried out similar to the step (ii) of example 6, using 2-nitrophenyl dimethylcarbamate instead of 4-nitrophenyl dimethylcarbamate.
Yield - 90%
Nature - pale yellow oil
HPLC Purity - 99.06% Example 9
Preparation of neostigmine methylsulphate (General procedure)
A 250 ml four neck round bottom flask was charged with 3-dimethylaminophenyl dimethylcarbamate obtained in the example 1, and acetone. Dimethyl sulphate (1.66 eq) was added drop wise to the flask at room temperature. The reaction mixture was stirred overnight, cooled to 5°C to 10°C for 2 hours, filtered and the filtrate was washed with isopropanol. The residue was dried under vacuum at room temperature to get crude neostigmine methylsulphate, which was purified by recrystallisation from isopropanol.
Yield - 85%
Nature - pale yellow oil
HPLC Purity - 99.21%
Similarly 3-dimethylaminophenyl dimethylcarbamate obtained in the examples 2 to 8 were quaternised to afford neostigmine methylsulphate in 81 to 92 % yield and 98.8 to 99.7 % HPLC purity.

Claims

We claim,
1. Process for preparing 3-dimethylaminophenyl dimethylcarbamate of formula (I)
H
Figure imgf000017_0001
Formula (I) comprising,
a. reacting diaryl carbonate of formula (II) with dimethylamine to form an aryl dimethylcarbamate of formula (III)
Figure imgf000017_0002
Formula (II) Formula (III) where Ri is an electron withdrawing group; R2 and R3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R2 and R3 when placed ortho to each other form benzene ring; R3 and R4 are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring; b. optionally isolating the aryl dimethylcarbamate of formula (III) obtained in the step 'a'; and c. reacting the aryl dimethylcarbamate of formula (III) obtained in step 'a' with 3- dimethylaminophenol.
2. The process as claimed in claim 1, wherein the process is carried out without isolating the aryl dimethylcarbamate of formula (III).
3. The process as claimed in claim 1, wherein Ri is selected from N02, CN or CO-alkyl and R2 is hydrogen or electron withdrawing group selected from N02, CN or CO-alkyl.
4. The process as claimed in claims land 3, wherein R) is N02; R2 is N02 or hydrogen; and R3 is hydrogen.
5. The process as claimed in claim 1, wherein the step 'a' is carried out in presence of a solvent.
6. The process as claimed in claim 1, wherein the step 'c' is carried out in presence of a base and a solvent.
7. The process as claimed in claim 6, wherein the base for the step 'c' is selected form atleast one inorganic base.
8. The process as claimed in claim 7, wherein the base is potassium hydroxide.
9. The process as claimed in claims 5 and 6 wherein the solvent is selected from polar solvent, non polar solvent or mixture thereof.
10. The process as claimed in claim 9 wherein the solvent is toluene.
11. Process for preparing 3-dimethylaminophenyl dimethylcarbamate of formula (I)
Figure imgf000018_0001
Formula (I)
comprising,
i. reacting dimethylcarbamoyl chloride with a phenolic compound of formula (IV) to form an aryl dimethylcarbamate of formula (III).
Figure imgf000019_0001
Formula (III) Formula (IV) where Rj is an electron withdrawing group; R2 and R3 are independently hydrogen, electron withdrawing group, alkyl containing 1 to 7 carbon atoms, alkoxy containing 1 to 7 carbon atoms, halogen, NR3R4, mercapto, thioalkyl containing 1 to 7 carbon atoms, or R2 and R3 when placed ortho to each other form benzene ring; R3 and > are independently hydrogen, alkyl containing 1 to 7 carbon atoms, or R3 and R4 together with nitrogen form 3 to 7 members heterocyclic ring;
11. optionally isolating the aryl dimethylcarbamate of formula (III) obtained in step a; and iii. reacting the aryl dimethylcarbamate of formula (III) obtained in step 'a' with 3- dimethylaminophenol.
12. The process as claimed in claim 11, wherein the process is carried out without isolating aryl dimethylcarbamate of formula (III).
13. The process as claimed in claim 11, wherein Ri is selected from N02, CN or CO-alkyl and R2 is hydrogen or electron withdrawing group selected from N02, CN or CO-alkyl.
14. The process as claimed in claims 11 and 13, wherein R is N02; R2 is N02 or hydrogen; and R3 is hydrogen.
15. The process as claimed in claim 1 1, wherein the steps 'i' and ii' are carried out in presence of a base and a solvent.
16. The process as claimed in claims 11 and 15, wherein the base for the step 'i' is selected from organic base, inorganic base or mixture thereof.
17. The process as claimed in claim 16, wherein the base for the step 'i' is triethylamine.
18. The process as claimed in claims 11 and 15, wherein the base for the step 'iii' is selected from atleast one inorganic base.
19. The process as claimed in claim 18, wherein the base for the step Mii' is potassium hydroxide.
20. The process as claimed in claims 11 and 15, wherein the solvent is selected from polar solvent, non polar solvent or mixture thereof.
21. The process as claimed in claim 20, wherein the solvent is toluene.
PCT/IN2011/000721 2011-03-30 2011-10-18 Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate WO2012131699A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN998/MUM/2011 2011-03-30
IN998MU2011 2011-03-30

Publications (1)

Publication Number Publication Date
WO2012131699A1 true WO2012131699A1 (en) 2012-10-04

Family

ID=45464056

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000721 WO2012131699A1 (en) 2011-03-30 2011-10-18 Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate

Country Status (1)

Country Link
WO (1) WO2012131699A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175238A1 (en) * 2016-04-07 2017-10-12 Neon Laboratories Limited Highly chemoselective reactions in presence of aromatic amino groups
CN116082193A (en) * 2022-10-24 2023-05-09 云南先施药业有限公司 Preparation and purification method of neostigmine methosulfate

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB342237A (en) 1930-05-30 1931-01-29 Hoffmann La Roche Process for the manufacture of products for destroying animals
DE535835C (en) * 1928-12-04 1931-10-27 Hoffmann La Roche & Co Akt Ges Process for the preparation of mono- and disubstituted carbamic acid esters
US1905990A (en) 1931-01-02 1933-04-25 Hoffmann La Roche Disubstituted carbamic acid esters of phenols containing a basic constituent
US4315861A (en) 1979-11-08 1982-02-16 Chinoin Gyogyszer RT Process for O-acylating phenol derivatives and acylating compositions for this purpose
EP0193926A2 (en) 1985-03-05 1986-09-10 Proterra Ag Phenyl carbamates
US20100113819A1 (en) 2008-11-03 2010-05-06 Sabic Innovative Plastics Ip Bv Method for Making Carbamates, Ureas and Isocyanates

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE535835C (en) * 1928-12-04 1931-10-27 Hoffmann La Roche & Co Akt Ges Process for the preparation of mono- and disubstituted carbamic acid esters
GB342237A (en) 1930-05-30 1931-01-29 Hoffmann La Roche Process for the manufacture of products for destroying animals
US1905990A (en) 1931-01-02 1933-04-25 Hoffmann La Roche Disubstituted carbamic acid esters of phenols containing a basic constituent
US4315861A (en) 1979-11-08 1982-02-16 Chinoin Gyogyszer RT Process for O-acylating phenol derivatives and acylating compositions for this purpose
EP0193926A2 (en) 1985-03-05 1986-09-10 Proterra Ag Phenyl carbamates
US20100113819A1 (en) 2008-11-03 2010-05-06 Sabic Innovative Plastics Ip Bv Method for Making Carbamates, Ureas and Isocyanates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOSE E. BARBARINI ET AL: "Synthesis of Some New o-Substituted Arylcarbamates and Related Compounds", BIOORGANIC CHEMISTRY 25, 1 January 1997 (1997-01-01), pages 37 - 41, XP055027436, Retrieved from the Internet <URL:http://ac.els-cdn.com/S0045206896910536/1-s2.0-S0045206896910536-main.pdf?_tid=777507fa7505d3a7916b373260e9037a&acdnat=1337168405_9dbb3670ae94f392af4587c97d1cb332> [retrieved on 20120516] *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175238A1 (en) * 2016-04-07 2017-10-12 Neon Laboratories Limited Highly chemoselective reactions in presence of aromatic amino groups
CN116082193A (en) * 2022-10-24 2023-05-09 云南先施药业有限公司 Preparation and purification method of neostigmine methosulfate

Similar Documents

Publication Publication Date Title
ES2431618T3 (en) A process for the preparation of 6- (7 - ((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide and synthetic intermediates thereof
EP3392238B1 (en) Production method for isocyanate compound
US4395558A (en) 9-Epi-mitomycin B and D compounds
CZ307789B6 (en) Method of producing biologically active phosphoramidate medicaments
WO2012131699A1 (en) Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate
JPH0114218B2 (en)
WO2014125499A1 (en) Improved and commercially viable process for the preparation of high pure plerixafor base
US10053419B2 (en) Isocyanate compound manufacturing method
US4725680A (en) Process for the preparation of carbamates, thiocarbamates and ureas
EP0018583B1 (en) Process for the preparation of aryl-mono-,-di-and/or polyurethanes-
WO2014024207A1 (en) Process for preparation of succinylcholine chloride
US5393894A (en) Process for the preparation of N-ethylcarbazole
DE2245392C3 (en) Process for the preparation of N-tert-butyloxycarbonyl, N-tert-amyloxycarbonyl or N-4-methoxybenzyloxycarbonylaminocarboxylic acids or peptides
CN114644590B (en) Process for preparing dichloropyrimidine
CN114644592B (en) Process for preparing dichloropyrimidine
CN114644593B (en) Process for preparing dichloropyrimidine
US20050065361A1 (en) Process for preparing alkyl/aryl chloroformates
US3839394A (en) Process for the preparation of substituted dinitrophenyl chloroformates
CZ288684B6 (en) Process for preparing 3,4-dihydroxy-5-nitrobenzaldehyde
GB2065639A (en) N-carbamoyl-saccharin derivatives and their use as acylating agents in the preparation of phenyl carbamate derivatives
IL28661A (en) Process for the manufacture of n-carbamoyloxyphenylcarbamates
WO2009049837A1 (en) Process for preparing 8-hydrazino-8-aryloctanoyl derivatives and their use
EP0279366B1 (en) Process for the preparation of pyrimidines
EP1833814A2 (en) Method for the production of substituted 2-alkoxycarbonyl-3-aminothiophenes
EP0641764A2 (en) Process for the preparation of hydroxyalkylaminonitrobenzene derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11805641

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11805641

Country of ref document: EP

Kind code of ref document: A1